While the June 2017 deal between Medtronic PLC and Aetna Inc. relating to the supply of insulin pumps was not unique, it was notable because it illustrates how supply deals in the medtech sector are increasingly likely to be structured in the future.
Medtronic’s Deal With Aetna Heralds New Value-Based Era
Medtronic's outcomes-based insulin pump supply deal with Aetna is the latest example of the medtech industry's shift toward value-based care.